Company Profile

Dr. Reddy's Laboratories Ltd Stock Price, News & Analysis

Ticker:
RDY
Exchange:
NYSE
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NYSE, Dr. Reddy's Laboratories Ltd is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.

Stock performance

14.31 USD (+2.88%)

Close

Last updated: June 23, 2026 at 00:00

11.92B USD

Market cap

Why the stock is moving

RDY is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Dr. Reddy's Laboratories Ltd is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NYSE, Dr. Reddy's Laboratories Ltd is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.

Business Model Characteristics

Dr. Reddy's Laboratories Ltd is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.

Position Within the Biotechnology Landscape

Compared with therapeutic biotech names, Dr. Reddy's Laboratories Ltd sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Dr. Reddy's Laboratories Ltd (RDY)?

    Dr. Reddy's Laboratories Ltd (RDY) most recently closed at 14.31 USD, a +2.88% move versus the previous session.

    What is the market cap of Dr. Reddy's Laboratories Ltd (RDY)?

    Dr. Reddy's Laboratories Ltd currently has a market capitalization of 11.92B USD on BioPharmSignal.

    What does Dr. Reddy's Laboratories Ltd do?

    Dr. Reddy's Laboratories Ltd is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

    On which exchange is RDY stock listed?

    Dr. Reddy's Laboratories Ltd (RDY) is associated with NYSE, Headquartered in the United States and listed on NYSE, Dr. Reddy's Laboratories Ltd is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles., Biotechnology.

    What is Reddy?

    Reddy's Laboratories Ltd is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

    Which conditions is Dr. Reddy's Laboratories Ltd targeting with Reddy?

    Dr. Reddy's Laboratories Ltd is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

    What is Laboratories?

    Reddy's Laboratories Ltd is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.